| # | Drug | Count |
|---|---|---|
| 0 | ONABOTULINUMTOXINA | 21 |
| 1 | MIRABEGRON | 20 |
| 2 | METHOTREXATE SODIUM | 16 |
| 3 | CELECOXIB | 15 |
| 4 | GOLIMUMAB | 15 |
| 5 | INFLIXIMAB | 15 |
| 6 | NAPROXEN | 15 |
| 7 | NAPROXEN SODIUM | 15 |
| 8 | INFLIXIMAB-DYYB | 14 |
| 9 | METHOTREXATE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 14 | 0.0041 |
| 1 | DANTROLENE SODIUM | 2 | 0.0017 |
| 2 | GOLIMUMAB | 15 | 0.0012 |
| 3 | NERANDOMILAST | 1 | 0.0006 |
| 4 | SOLIFENACIN SUCCIATE | 1 | 0.0005 |
| 5 | MIRABEGRON | 20 | 0.0005 |
| 6 | SILODOSIN | 2 | 0.0005 |
| 7 | FESOTERODINE FUMARATE | 5 | 0.0005 |
| 8 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| 9 | VIBEGRON | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | beta3-Adrenergic Agonist [EPC] | 23 | 0.0005 |
| 1 | Acetylcholine Release Inhibitor [EPC] | 24 | 0.0002 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 5 | 0.0000 |
| 4 | Angiotensin Converting Enzyme Inhibitor [EPC] | 6 | 0.0000 |
| 5 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 13 | 0.0000 |
| 8 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 9 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |